These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6671252)

  • 1. Syntheses of 5-substituted oxazole-4-carboxylic acid derivatives with inhibitory activity on blood platelet aggregation.
    Ozaki Y; Maeda S; Iwasaki T; Matsumoto K; Odawara A; Sasaki Y; Morita T
    Chem Pharm Bull (Tokyo); 1983 Dec; 31(12):4417-24. PubMed ID: 6671252
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.
    Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Zavoico GB
    J Med Chem; 1992 Sep; 35(19):3483-97. PubMed ID: 1404230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
    Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P
    Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and inhibitory effect on platelet aggregation and antihypertensive activity of 1-hydroxy-2,5-dihydro-1H-imidazole-2-carboxylic acid 3-oxides, 1,3-dihydroxyimidazolidine-2-carboxylic acids, and 1,4-dihydroxy-2,3-piperazinediones.
    Tikhonov YaA ; Mazhukin DG; Grigor'eva LN; Khlestkin VK; Voinova NN; Syropyatov YaB ; Shirinkina SS; Volodarsky LB
    Arch Pharm (Weinheim); 1999 Sep; 332(9):305-8. PubMed ID: 10520299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
    Moriya T; Seki M; Takabe S; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    J Med Chem; 1988 Jun; 31(6):1197-204. PubMed ID: 3373489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile preparation of oxazole-4-carboxylates and 4-ketones from aldehydes using 3-oxazoline-4-carboxylates as intermediates.
    Murai K; Takahara Y; Matsushita T; Komatsu H; Fujioka H
    Org Lett; 2010 Aug; 12(15):3456-9. PubMed ID: 20608663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds.
    Takeuchi K; Kohn TJ; True TA; Mais DE; Wikel JH; Utterback BG; Wyss VL; Jakubowski JA
    J Med Chem; 1998 Dec; 41(27):5362-74. PubMed ID: 9876106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiplatelet activity of new imidazole-4-carboxylic acid derivatives.
    Rehse K; Steege J
    Arch Pharm (Weinheim); 2005 Nov; 338(11):539-47. PubMed ID: 16281307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Amino-2-oxazolines, III: Synthesis, structure, and preliminary pharmacological evaluation of cycloaddition compounds with unsaturated carboxylic esters.
    Forfar I; Jarry C; Leger JM; Carpy A
    Arch Pharm (Weinheim); 1990 Nov; 323(11):905-9. PubMed ID: 2080898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new and efficient access to oxazoline-5-carboxylates and amino acid derivatives with cyclopropyl groups.
    Nötzel MW; Tamm M; Labahn T; Noltemeyer M; Es-Sayed M; de Meijere A
    J Org Chem; 2000 Jun; 65(12):3850-2. PubMed ID: 10864774
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of 5-amino-oxazole-4-carboxylates from alpha-chloroglycinates.
    Zhang J; Coqueron PY; Vors JP; Ciufolini MA
    Org Lett; 2010 Sep; 12(17):3942-5. PubMed ID: 20698488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhodium carbene routes to oxazoles and thiazoles. Catalyst effects in the synthesis of oxazole and thiazole carboxylates, phosphonates, and sulfones.
    Shi B; Blake AJ; Lewis W; Campbell IB; Judkins BD; Moody CJ
    J Org Chem; 2010 Jan; 75(1):152-61. PubMed ID: 19954177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and some biological properties of 2-xanthonylalkyl-(alkoxy) carboxylic acids.
    Marona H; Eckstein M; Krupińska J; Mazur J; Piotrowicz J; Cebo B
    Pol J Pharmacol Pharm; 1986; 38(1):107-14. PubMed ID: 3489931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palladium-catalyzed direct (hetero)arylation of ethyl oxazole-4-carboxylate: an efficient access to (hetero)aryloxazoles.
    Verrier C; Martin T; Hoarau C; Marsais F
    J Org Chem; 2008 Sep; 73(18):7383-6. PubMed ID: 18702548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New oxazolines with potential anti-inflammatory and circulatory activity].
    Cantarelli G; Gentili P
    Boll Chim Farm; 1980 Mar; 119(3):144-8. PubMed ID: 7459035
    [No Abstract]   [Full Text] [Related]  

  • 17. Indolizine derivatives with biological activity I: N'-substituted hydrazides of indolizine-2-carboxylic acid.
    Cardellini M; Claudi F; Grifantini M; Gulini U; Martelli S
    J Pharm Sci; 1977 Feb; 66(2):259-62. PubMed ID: 839424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new derivatives of the 4,5-diphenyloxazole series.
    Mattalia G; Serafini C; Bucciarelli U
    Farmaco Sci; 1976 Jun; 31(6):457-67. PubMed ID: 1278364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6.
    Tanaka A; Hattori K; Taniguchi K; Okitsu O; Tabuchi S; Nishio M; Nagakura Y; Maeda N; Murai H; Seki J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4861-4. PubMed ID: 16837197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism investigation leading to novel drug design: orally active prostacyclin mimetics. Part 4.
    Hattori K; Takamura F; Tanaka A; Takasugi H; Taniguchi K; Nishio M; Koyama S; Seki J; Sakane K
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3284-7. PubMed ID: 15935659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.